Japanese researchers believe they’ve identified a genetic risk marker that could pinpoint which people with atrial fibrillation (AFib) are at risk of developing tachycardia-induced cardiomyopathy (TIC).

“[TIC] is a…

Home-delivered sodium-restricted Dietary Approaches to Stop Hypertension (DASH/SRD) meals after heart failure (HF) hospitalizations appeared safe in some patients, has the potential to improve HF symptoms and can reduce readmissions, according to…

In a single-center study of smokers with heart failure, those who also had emphysema identified by CT were twice as likely to be rehospitalized for heart failure in the following two years. In addition, they demonstrated 70…

While heart failure (HF) is an uncommon complication of breast cancer, a new study in the Journal of…

A program designed to provide rapid follow-up visits to heart failure patients after hospital discharge improved 30-day survival, reduced readmissions and saved money, according to a…

A protein known to protect brain function in the setting of Duchenne muscular dystrophy may also have a positive impact on the heart, according to preliminary research presented at the American Heart Association’s Basic Cardiovascular…

Continually updated mortality models based on adverse events and end-organ function are better at showing which transplant candidates most urgently require a new heart, according to a study published in the …

A simple measure of waist circumference could identify chronic heart failure patients who would benefit most from mineralocorticoid receptor antagonists, according to a review published July 25 in …

In following more than 1,100 patients with heart failure for up to 15 years, Spanish cardiologists found left ventricular ejection fraction (LVEF) followed an inverse U-shape: LVEF improved for the first year, then plateaued for the rest of…

Italian physicians reported what they believe to be “unprecedented clinical improvement” from interleukin-1 suppression in a patient with dilated cardiomyopathy.

Writing in the …

Twice as many U.S. deaths due to cardiac amyloidosis were reported in 2015 than in 1979, but a study in JAMA Cardiology suggests the disease remains…

Despite decreases in heart failure (HF) incidences and mortality rates in ambulatory patients, mortality remains higher for women, according to a study published July 16 in the Canadian Medical…

Stem cells were used to “encourage” better function in heart failure patients in the U.K., according to a recent stem cell therapy trial spearheaded by researchers from the University of Edinburgh. Harvested from bone marrow, the stem cells,…

Despite guidelines and quality improvement efforts, many people with heart failure with reduced ejection fraction (HFrEF) aren’t prescribed the recommended medications. And among those who are, fewer than one-fourth receive optimal doses,…

A new study, published July 11 in the Journal of the American Medical Association, suggests heart failure (HF) may be moderately hereditary.

…

The FDA has cleared a less-invasive implant approach for Medtronic’s HeartWare HVAD system, allowing the left ventricular assist device (LVAD) to be placed through a small incision between the ribs. It is the first LVAD approved in the U.S…

New research published in the Journal of the American Medical Association suggests an association between black postmenopausal women who are carriers of apolipoprotein L1 (APOL1) genotypes and hospitalizations for heart failure…

Human stem cells helped restore left ventricular ejection fraction (LVEF) in monkeys induced with experimental heart failure, giving scientists hope that a similar treatment could work in humans following myocardial infarction.…

An online tool to help determine which patients might benefit the most from implantable cardioverter defibrillators (ICDs) is now available for cardiologists via the University of Washington…

Just a week after Baylor St. Luke’s Medical Center in Houston reopened its heart transplant program, CMS sent a letter to the hospital saying it will cut off funding for the program beginning Aug. 17.

The program was…

Continuing cardiac resynchronization therapy (CRT) appeared to offer no benefit to patients who received a continuous flow left ventricular assist device (CF-LVAD), according to a multicenter…